Ordena

Cercar

15/03/2024 Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction
Vilahur, G, Radike, M, Sutelman, P, Ben-Aicha, S, Gutiérrez, M, Casaní, L, Hovdal, D, Ongstad, EL, Gabrielsen, A, Hidalgo, A, Fjellström, O, Carlsson, L, Badimon, L. Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction. EUROPEAN HEART JOURNAL. 2024; 45(17)DOI:10.1093/eurheartj/ehae107. PMID:38486376. IF:35.600(Q1/1D).
14/03/2024 Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium
Daniels, C, Rodriguez-Antigueedad, J, Jentschke, E, Kulisevsky, J, Volkmann, J. Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium. Neurological Research And Practice. 2024; 6(1)DOI:10.1186/s42466-024-00309-4. PMID:38481336. IF:(Q/D).
14/03/2024 Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population
Pesiou, S, Barcelo, R, Papazisis, G, Torres, F, Pontes, C. Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population. Frontiers in Pharmacology. 2024; 15DOI:10.3389/fphar.2024.1348887. PMID:38549664. IF:4.800(Q1/2D).
13/03/2024 Robotic kidney transplantation
Basile, G, Pecoraro, A, Gallioli, A, Territo, A, Berquin, C, Robalino, J, Bravo, A, Huguet, J, Rodriguez-Faba, O, Gavrilov, P, Facundo, C, Guirado, L, Gaya, JM, Palou, J, Breda, A. Robotic kidney transplantation. Nature Reviews Urology. 2024; 21(9)DOI:10.1038/s41585-024-00865-z. PMID:38480898. IF:14.600(Q1/1D).
13/03/2024 Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function
Borrell-Pages, M, Luquero, A, Vilahur, G, Padró, T, Badimon, L. Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function. CARDIOVASCULAR RESEARCH. 2024; 120(2)DOI:10.1093/cvr/cvad159. PMID:37882606. IF:13.300(Q1/1D).
13/03/2024 PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023)
O'Toole, D, Kunz, PL, Webb, SM, Goldstein, G, Khawaja, S, McDonnell, M, Boiziau, S, Gueguen, D, Houchard, A, Ribeiro-Oliveira, A Jr, Prebtani, A. PRESTO 2: An International Survey to Evaluate Patients' Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly (vol 40, pg 671, 2023). ADVANCES IN THERAPY. 2024; 41(6)DOI:10.1007/s12325-024-02829-6. PMID:38480663. IF:4.000(Q1/3D).